尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Hineline Lawrence J., 首席财务官. Director active across 1 company, notably Intra-Cellular Therapies, Inc.. Aggregated, 13 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €396k. History available since 21 December 2021. The latest transaction was filed on 7 March 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Hineline Lawrence J. is Directeur Financier at Intra-Cellular Therapies, Inc. The 13 filings recorded cover the period from 2021-12-23 to 2024-03-11, and among the recent filings observed, the sell amount is EUR 395996, with option exercises as the most common transaction type.